FDA NDC Directory · JSON-LD · Markdown

Febuxostat

NDC 0054-0413 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerHikma Pharmaceuticals USA Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA205414
Dosage form / routeTABLET · ORAL
Active ingredientsFEBUXOSTAT (40 mg/1)
Marketing started20191111
Package count1

External sources

Source: openFDA. Public-domain (CC0).